DWS - Biotech Typ O
Country/Region
North America
Sector
Biotechnologie
Performance (1Y)
34.87%
Total expense ratio (TER)
1.50 %
Investment fund volume
343,636,805
Appropration of income
Accumulation
Facts & figures
Price data
| TRADE PLATFORM | ||
| LAST PRICE | 308.14 G | 0 Units |
| PRICE DETERMINATION TIME | 06/19/2026 / 09:56:11 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 310.54 | 308.04 |
| PREV. DAY'S PRICE | 310.22 | (06/18) |
| CHANGE DAY BEFORE | -2.08 | -0.67 % |
| 52 WEEK HIGH / LOW | 320.98 (04/20) | 224.56 (06/26) |
Master Data
| WKN | 976997 |
| ISIN | DE0009769976 |
| SYMBOL | DWWD |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Fund |
| MANAGEMENT TYPE | Active |
| INVESTMENT FUND TYPE | Equity Fund |
| PRODUCT DENOMINATION | DWS - Biotech Typ O |
| MARKET MAKER | - |
| COUNTRY/REGION | North America |
| ISSUER/INVESTMENT COMPANY | DWS Investment GmbH |
| MAPPED INDEX/BENCHMARK | NASDAQ Biotechnology Index |
| INDUSTRY | Biotechnologie |
| FUND CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| DISTRIBUTION | Accumulation |
| TER | 1.50 % |
| LISTING DATE | 20/11/2000 |
| INVESTMENT FUND VOLUME | 343,636,804.91 |
| END OF FINANCIAL YEAR | 30/09/2026 |
| LICENSED FOR SALE IN GERMANY | Yes |
| TRADING HOURS | 07:30 - 22:00 |
| QUOTATION | continuous auction |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 2.74 % | 2.91 % | 3.08 % | 2.00 % | 34.87 % | 24.23 % | 23.85 % | 0.02 % |
| HIGH | 310.92 | 311.62 | 320.98 | 320.98 | 320.98 | 320.98 | 320.98 | 320.98 |
| LOW | 300.32 | 292.76 | 290.42 | 290.42 | 224.56 | 202.22 | 184.95 | 290.42 |
Investment strategy
Description
Das Fondsvermoegen wird weltweit in Aktien von Biotechnologieunternehmen investiert, wobei der regionale Schwerpunkt in den USA liegt. Dem Portfolio koennen auch interessante Pharma- und Medizintechnikunternehmen beigemischt werden.